Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$27,314,621
+$6,742,126 QoQ
Shares Held
22,773
+1.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#753
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Advisors Asset Management, Inc. holds $248,035,659 across 15 Drug Manufacturers - General names. LLY ranks #4 (11.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
346,193 | $44,485,800 | |
| 2 | AMGN |
Amgen Inc
|
97,240 | $35,212,548 | |
| 3 | JNJ |
Johnson & Johnson
|
137,584 | $34,942,208 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
22,773 | $27,314,621 | |
| 5 | ABBV |
AbbVie Inc.
|
87,496 | $22,017,493 | |
| 6 | PFE |
Pfizer Inc
|
873,428 | $21,032,146 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
302,317 | $17,419,505 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
127,450 | $16,102,033 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,314,621 | 22,773 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $20,572,495 | 22,367 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $24,424,254 | 22,727 | Shares | Sole | 2026-08-21 | |
| 2025-09-30 | $18,060,973 | 23,671 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $18,783,554 | 24,096 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $21,566,161 | 26,112 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $24,219,956 | 31,373 | Shares | Sole | 2026-08-21 | |
| 2024-09-30 | $36,263,296 | 40,932 | Shares | Sole | 2026-08-21 | |
| 2024-06-30 | $43,326,054 | 47,854 | Shares | Sole | 2026-08-21 | |
| 2024-03-31 | $45,793,059 | 58,863 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $39,346,517 | 67,499 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $40,615,084 | 75,615 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $35,180,065 | 75,014 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $27,092,060 | 78,889 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $28,561,128 | 78,070 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $28,828,592 | 89,156 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $28,971,571 | 89,355 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $27,607,213 | 96,404 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $27,946,558 | 101,175 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $23,163,917 | 100,255 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $23,036,233 | 100,367 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $20,034,389 | 107,239 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $16,742,512 | 99,162 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $13,688,297 | 92,476 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $15,316,188 | 93,289 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $12,328,601 | 88,874 | Shares | Sole | 2026-08-21 | |
| No filing history on record for this holder in this stock. | ||||||